Fact CheckerSign in

NCT07041775Recruiting

MINT Conditioning to Improve Gait

MINT Conditioning to Improve Post-stroke Gait

Source: ClinicalTrials.gov · Last updated 8 Jun 2026

Brief summary (registry, in English)

This study will test the ability of myoelectric interface for neurorehabilitation (MINT) training to improve walking function.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
72 (estimated)
First submitted
29 May 2025
Start date
4 Jun 2026
Primary completion date
Jan 2030
Lead sponsor
Northwestern University
Diseases
Stroke
NCT number
NCT07041775

What you commit to

  • Study type: Interventional
  • Planned participants: 72
  • From 4 Jun 2026 to the primary completion date, Jan 2030
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Cognitive impairment with at least moderately impaired attention on digit-span test, or unable to follow instructions of the MINT task
  • Visual impairment (such as hemianopia) preventing sufficient perception of the screen to play the games
  • Anesthesia or severe neglect in the affected leg, or visual hemineglect (score of 2 on the NIH Stroke Scale Extinction and Inattention subtest) that impairs ability to play the games
  • History of multiple falls within the last year, use of walker for balance, or falling during stance while in the lab in the first session.
  • From the TMS portion of the study only: History of epilepsy in adulthood requiring antiseizure medications; recent/current alcoholism or benzodiazepine/barbiturate abuse or recent history of alcohol/benzodiazepine/barbiturate withdrawal, recent history of cocaine or amphetamine use, skull fractures or skull deficits, concussion within the last 6 months, unexplained recurring headaches, vagus nerve stimulator, cochlear implant, deep brain stimulator, intracranial/carotid stents, cardiac pacemaker/AICD.

Other

  • Participation in another study on the affected leg, or any pharmacological study, within 6 weeks of enrollment
  • Inability to understand or follow commands in English due to aphasia or other reason that makes it impossible to perform the training
  • Diffuse or multifocal infarcts
  • Substantial leg or other pain preventing participation for 60 minutes a day
  • Spasticity treatment (pharmacological or Botox) on the affected leg within past 3 months
  • Severe osteoporosis causing hip or other fractures
  • Contracture limiting the range of motion of the leg
  • Current pregnancy

Who the study is looking for

  • Age at enrollment is 18 to 85
  • Leg impairment from unilateral stroke at least 6 months prior to screening
  • Severe to moderate gait impairment (ambulatory with a maximum walking speed of 0.8 m/s, i.e., half of normal speed)
  • Able to stand without assistance
  • Clinically observable gait asymmetry
  • Abnormal co-activation between adductor magnus and rectus femoris (R greater than or equal to 0.5)

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Northwestern University
Coordinator of this site? Confirm its status
ChicagoUnited StatesRecruiting
University of Texas Southwestern Medical Center
Coordinator of this site? Confirm its status
DallasUnited StatesNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.